196 related articles for article (PubMed ID: 37923740)
1. Inhibition of LSD1 induces ferroptosis through the ATF4-xCT pathway and shows enhanced anti-tumor effects with ferroptosis inducers in NSCLC.
Du L; Yang H; Ren Y; Ding Y; Xu Y; Zi X; Liu H; He P
Cell Death Dis; 2023 Nov; 14(11):716. PubMed ID: 37923740
[TBL] [Abstract][Full Text] [Related]
2. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
[TBL] [Abstract][Full Text] [Related]
3. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner.
Chen D; Fan Z; Rauh M; Buchfelder M; Eyupoglu IY; Savaskan N
Oncogene; 2017 Oct; 36(40):5593-5608. PubMed ID: 28553953
[TBL] [Abstract][Full Text] [Related]
4. E3 ligase Trim35 inhibits LSD1 demethylase activity through K63-linked ubiquitination and enhances anti-tumor immunity in NSCLC.
Tang F; Lu C; He X; Lin W; Xie B; Gao X; Peng Y; Yang D; Sun L; Weng L
Cell Rep; 2023 Dec; 42(12):113477. PubMed ID: 37979167
[TBL] [Abstract][Full Text] [Related]
5. Lysine-specific demethylase 1 aggravated oxidative stress and ferroptosis induced by renal ischemia and reperfusion injury through activation of TLR4/NOX4 pathway in mice.
Feng R; Xiong Y; Lei Y; Huang Q; Liu H; Zhao X; Chen Z; Chen H; Liu X; Wang L; Weng X
J Cell Mol Med; 2022 Aug; 26(15):4254-4267. PubMed ID: 35775122
[TBL] [Abstract][Full Text] [Related]
6. Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2).
Mino K; Nishimura S; Ninomiya S; Tujii H; Matsumori Y; Tsuchida M; Hosoi M; Koseki K; Wada S; Hasegawa M; Sasaki R; Murakami-Yamaguchi Y; Narita H; Suzuki T; Miyata N; Mizukami T
Biosci Biotechnol Biochem; 2014; 78(6):1010-7. PubMed ID: 25036127
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
Vasilatos SN; Katz TA; Oesterreich S; Wan Y; Davidson NE; Huang Y
Carcinogenesis; 2013 Jun; 34(6):1196-207. PubMed ID: 23354309
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
[TBL] [Abstract][Full Text] [Related]
9. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes.
El Mansouri FE; Nebbaki SS; Kapoor M; Afif H; Martel-Pelletier J; Pelletier JP; Benderdour M; Fahmi H
Arthritis Res Ther; 2014 May; 16(3):R113. PubMed ID: 24886859
[TBL] [Abstract][Full Text] [Related]
10. Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11.
Wang Y; Zhao Y; Wang H; Zhang C; Wang M; Yang Y; Xu X; Hu Z
FEBS Open Bio; 2020 Apr; 10(4):637-643. PubMed ID: 32107878
[TBL] [Abstract][Full Text] [Related]
11. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
[TBL] [Abstract][Full Text] [Related]
12. Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition.
Augert A; Eastwood E; Ibrahim AH; Wu N; Grunblatt E; Basom R; Liggitt D; Eaton KD; Martins R; Poirier JT; Rudin CM; Milletti F; Cheng WY; Mack F; MacPherson D
Sci Signal; 2019 Feb; 12(567):. PubMed ID: 30723171
[TBL] [Abstract][Full Text] [Related]
13. Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1.
Patrick NM; Griggs CA; Icenogle AL; Gilpatrick MM; Kadiyala V; Jaime-Frias R; Smith CL
J Steroid Biochem Mol Biol; 2017 Mar; 167():1-13. PubMed ID: 27645313
[TBL] [Abstract][Full Text] [Related]
14. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
[TBL] [Abstract][Full Text] [Related]
15. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis.
He F; Zhang P; Liu J; Wang R; Kaufman RJ; Yaden BC; Karin M
J Hepatol; 2023 Aug; 79(2):362-377. PubMed ID: 36996941
[TBL] [Abstract][Full Text] [Related]
16. Discovery of WS-384, a first-in-class dual LSD1 and DCN1-UBC12 protein-protein interaction inhibitor for the treatment of non-small cell lung cancer.
Li A; Ma T; Wang S; Guo Y; Song Q; Liu H; Yu B; Feng S
Biomed Pharmacother; 2024 Apr; 173():116240. PubMed ID: 38401512
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
[TBL] [Abstract][Full Text] [Related]
18. Silencing of LSD1 gene modulates histone methylation and acetylation and induces the apoptosis of JeKo-1 and MOLT-4 cells.
Zou ZK; Huang YQ; Zou Y; Zheng XK; Ma XD
Int J Mol Med; 2017 Aug; 40(2):319-328. PubMed ID: 28627608
[TBL] [Abstract][Full Text] [Related]
19. Pilocarpine-induced seizures associate with modifications of LSD1/CoREST/HDAC1/2 epigenetic complex and repressive chromatin in mice hippocampus.
Noches V; Rivera C; González MP; Merello G; Olivares-Costa M; Andrés ME
Biochem Biophys Rep; 2021 Mar; 25():100889. PubMed ID: 33426312
[TBL] [Abstract][Full Text] [Related]
20. Lysine specific demethylase 1 inhibitor alleviated lipopolysaccharide/D-galactosamine-induced acute liver injury.
Wang X; Sun Y; Fu Y; Wu H; Chen Y; Ye Y; Zhou Q; He L; Zhou E; Wang J; Yang Z
Eur J Pharmacol; 2022 Oct; 932():175227. PubMed ID: 36007605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
